BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 51 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 51 minutes ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 16 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 24 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
Market News

Constellation Brands (STZ): Three factors that work in favor of this brewer

Shares of Constellation Brands Inc. (NYSE: STZ) were down 1% on Tuesday. The stock has gained 6% over the past one month. The company delivered strong demand for its most recent quarter helped by strong demand for its brands and changes to its portfolio. Here’s a look at three factors that work in favor of […]

$STZ November 15, 2022 3 min read

Shares of Constellation Brands Inc. (NYSE: STZ) were down 1% on Tuesday. The stock has gained 6% over the past one month. The company delivered strong demand for its most recent quarter helped by strong demand for its brands and changes to its portfolio. Here’s a look at three factors that work in favor of this brewer:

Revenue and profitability 

Constellation reported revenue and earnings growth for the second quarter of 2023. Net sales increased 12% year-over-year to $2.7 billion, helped by strong consumer demand for its products. Adjusted EPS increased 33% to $3.17. Reported operating income increased 10% to $813 million. For fiscal year 2023, the company expects reported EPS to be $0.75-1.15 and adjusted EPS to be $11.20-11.60.

Constellation Brands Q2 2023 earnings infographic

Strong performance in beer

Constellation witnessed strong performance in its beer business, driven by solid demand for its brands. In Q2, the beer business posted depletion growth of 9%, driven by strength in Modelo Especial and Corona Extra. Modelo Especial garnered the maximum share in the entire US beer category with depletion growth of over 10%. Corona Extra delivered depletion growth of 6%. The Modelo Chelada brands delivered depletion growth of over 60% in Q2.

The strong demand for its brands helped drive a 15% growth in net sales for the beer business in Q2. Operating income for the division gained 25% in the quarter. This momentum led Constellation to increase its guidance for the beer business. The company now expects net sales to grow 8-10% and operating income to grow 3-5% in FY2023.

Wine and spirits portfolio transformation

In Q2, net sales for the wine and spirits business inched up just 1% to $515.8 million, driven by an increase in bulk sales and favorable pricing. However, depletion growth was solid for its premium wine brands like Kim Crawford, Robert Mondavi and Meiomi.

ADVERTISEMENT

The company’s efforts in revamping its wine and spirits portfolio is paying off. It has been moving from the mainstream segment and focusing more on the higher end of the market. In Q2, its largest premium and fine wine brands and craft spirits brands delivered strong depletion growth rates. As part of its strategy to premiumize its business, it divested a portion of its mainstream wine portfolio along with a couple of select premium brands to The Wine Group.

Wine and spirits DTC net sales grew 15% in Q2 while international sales grew 10%. Constellation plans to focus on the growth of its omnichannel and international footprint as it expects these channels to make up a larger portion of its mix over time and provide an important opportunity for higher-end growth.

For FY2023, wine and spirits net sales are expected to be flat to down 2% while operating income is expected to increase 3-5%. This would imply operating margin of about 24% for the year for the segment.

Click here to read the full transcript of Constellation Brands’ Q2 2023 earnings conference call

ADVERTISEMENT